SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 134 filers reported holding SAGE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $72,517,000 | +32.4% | 1,420,226 | +19.4% | 0.01% | +18.2% |
| Q3 2016 | $54,758,000 | +75.1% | 1,189,093 | +14.6% | 0.01% | +57.1% |
| Q2 2016 | $31,273,000 | +23.9% | 1,037,928 | +31.8% | 0.01% | +16.7% |
| Q1 2016 | $25,249,000 | -35.6% | 787,546 | +17.1% | 0.01% | -33.3% |
| Q4 2015 | $39,208,000 | +25.5% | 672,519 | -8.9% | 0.01% | +12.5% |
| Q3 2015 | $31,251,000 | -38.4% | 738,434 | +6.3% | 0.01% | -33.3% |
| Q2 2015 | $50,696,000 | +109.6% | 694,471 | +44.2% | 0.01% | +100.0% |
| Q1 2015 | $24,188,000 | +43.1% | 481,540 | +4.2% | 0.01% | +50.0% |
| Q4 2014 | $16,907,000 | +279.0% | 461,948 | +226.2% | 0.00% | +300.0% |
| Q3 2014 | $4,461,000 | – | 141,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |